Found 602 matching trials
Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System NA The aim of this study is to establish a selection criteria of hepatectomy f...
Show More Location
Eastern hepatobilliary surgery hospital
Learn More & Join Trial
A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection PHASE3 To compare the impact on recurrence risk of adjuvant Sintilimab (a recombin...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Perioperative Therapy for Hepatocellular Carcinoma PHASE2 This study aims to observe and evaluate the efficacy and safety of the peri...
Show More Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
ThinkRadial: A Prospective Study of Transradial deTACE in HCC Patients N/A This study is a prospective, observational clinical trial designed to evalu...
Show More Location
Asan Medical Center
Learn More & Join Trial
Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma PHASE3 Hepatocellular carcinoma (HCC) is one of the most common solid cancers worl...
Show More Location
Chia-Yi Christine Hospital
Learn More & Join Trial
Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein Thrombosis PHASE4 Portal vein tumor invasion (PVT) is a common complication in HCC. the study...
Show More Location
Multiple Locations
Learn More & Join Trial
TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC) PHASE1 Liver metastases are a leading cause of death among patients with metastati...
Show More Location
Abramson Cancer Center
Learn More & Join Trial
Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT N/A This multicenter retrospective study evaluated consecutive patients with la...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Camrelizumab in Patients With Unresectable Hepatocellular Carcinoma N/A Primary liver cancer is the second most common cause of cancer death in Chi...
Show More Location
Multiple Locations
Learn More & Join Trial
TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer PHASE2 Vast majority of patients with hepatocellular carcinoma (HCC) present with ...
Show More Location
Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
Learn More & Join Trial